HAIWICK; Gregory

Patent Applications and Registrations

Patent applications and USPTO patent grants for HAIWICK; Gregory.The latest application filed is for "pcv2 orf2 protein variant and virus like particles composed thereof".

Company Profile

2.6.12

HAIWICK; Gregory - Ankeny IA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pcv2 Orf2 Protein Variant And Virus Like Particles Composed Thereof App 20210221852 - HERNANDEZ; Luis Alejandro ; et al.	2021-07-22
PCV2 ORF2 protein variant and virus like particles composed thereof Grant 10,961,281 - Hernandez , et al. March 30, 2	2021-03-30
Pcv2 Orf2 Protein Variant And Virus Like Particles Composed Thereof App 20190023747 - Hernandez; Luis Alejandro ; et al.	2019-01-24
PCV2 ORF2 protein variant and virus like particles composed thereof Grant 10,131,696 - Hernandez , et al. November 20, 2	2018-11-20
Porcine Circovirus Type 2 (pcv2) Subunit Vaccine App 20170232094 - HAIWICK; Gregory ; et al.	2017-08-17
Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity Grant 9,561,270 - Kohler , et al. February 7, 2	2017-02-07
Pcv2 Orf2 Protein Variant And Virus Like Particles Composed Thereof App 20170029471 - HERNANDEZ; Luis Alejandro ; et al.	2017-02-02
PCV2 ORF2 protein variant and virus like particles composed thereof Grant 9,505,808 - Hernandez , et al. November 29, 2	2016-11-29
Orf2 Protein Of Pcv2 Subtype A (pcv2a) For Use In Cross-protection App 20160206727 - HAIWICK; Gregory ; et al.	2016-07-21
Pcv2 Orf2 Protein Variant And Virus Like Particles Composed Thereof App 20150093404 - HERNANDEZ; Luis Alejandro ; et al.	2015-04-02
Porcine Circovirus Type 2 (pcv2) Subunit Vaccine App 20150056248 - HAIWICK; Gregory ; et al.	2015-02-26
Orf2 Protein Of Pcv2 Subtype A (pcv2a) For Use In Cross-protection App 20140322267 - HAIWICK; Gregory ; et al.	2014-10-30
Methods Of Reducing Virucidal Activity In Pcv-2 Compositions And Pcv-2 Compositions With An Improved Immunogenicity App 20110059126 - Kohler; Caroline Ann ; et al.	2011-03-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.